Daiwa Securities Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
245
| – | – | ﹤0.01% | 1194 |
|
|
2025
Q1 | $3K | Hold |
245
| – | – | ﹤0.01% | 1167 |
|
|
2024
Q4 | $5K | Hold |
245
| – | – | ﹤0.01% | 1163 |
|
|
2024
Q3 | $6K | Buy |
245
+93
| +61% | +$2.28K | ﹤0.01% | 1160 |
|
|
2024
Q2 | $3K | Hold |
152
| – | – | ﹤0.01% | 1223 |
|
|
2024
Q1 | $2K | Hold |
152
| – | – | ﹤0.01% | 1266 |
|
|
2023
Q4 | $2K | Hold |
152
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q3 | $1K | Hold |
152
| – | – | ﹤0.01% | 1259 |
|
|
2023
Q2 | $2K | Hold |
152
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q1 | $1K | Hold |
152
| – | – | ﹤0.01% | 1259 |
|
|
2022
Q4 | $2K | Hold |
152
| – | – | ﹤0.01% | 1224 |
|
|
2022
Q3 | $2K | Hold |
152
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q2 | $2K | Hold |
152
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $2K | Hold |
152
| – | – | ﹤0.01% | 1256 |
|
|
2021
Q4 | $4K | Hold |
152
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q3 | $5K | Buy |
152
+79
| +108% | +$2.6K | ﹤0.01% | 1173 |
|
|
2021
Q2 | $2K | Hold |
73
| – | – | ﹤0.01% | 1141 |
|
|
2021
Q1 | $2K | Hold |
73
| – | – | ﹤0.01% | 1147 |
|
|
2020
Q4 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 1125 |
|